Author:
Castellano Daniel,Grande Enrique,Valle Juan,Capdevila Jaume,Reidy-Lagunes Diane,O’Connor Juan Manuel,Raymond Eric
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference92 articles.
1. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Fave GD, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72. doi: 10.1016/S1470-2045(07)70410-2
2. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072. doi: 10.1200/JCO.2007.15.4377
3. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97:934–959. doi: 10.1002/cncr.11105
4. Oberg K (2005) Somatostatin-receptor mediated diagnosis and treatment in gastrointestinal neuroendocrine tumours (GEP-NET’s). Rocz Akad Med Bialymst 50:62–68
5. Oberg K (1999) Neuroendocrine gastrointestinal tumors—a condensed overview of diagnosis and treatment. Ann Oncol 10(Suppl 2):S3–S8
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献